ALLIANCEBERNSTEIN L.P. - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 86 filers reported holding RELMADA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 2.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$68,704
-35.2%
30,4000.0%0.00%
Q4 2022$106,096
-84.0%
30,400
+69.8%
0.00%
Q3 2022$663,000
-54.7%
17,900
-76.8%
0.00%
-100.0%
Q2 2022$1,463,000
+202.9%
77,032
+330.3%
0.00%
Q1 2022$483,000
+19.9%
17,9000.0%0.00%
Q4 2021$403,000
-14.1%
17,9000.0%0.00%
Q3 2021$469,000
-18.2%
17,9000.0%0.00%
Q2 2021$573,000
+3.6%
17,900
+14.0%
0.00%
Q1 2021$553,000
+9.9%
15,7000.0%0.00%
Q4 2020$503,000
-23.2%
15,700
-9.8%
0.00%
Q3 2020$655,000
-18.7%
17,400
-3.3%
0.00%
Q2 2020$806,00018,0000.00%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VR Adviser, LLC 668,440$25,147,0004.92%
TANG CAPITAL MANAGEMENT LLC 500,000$18,810,0003.40%
ACUTA CAPITAL PARTNERS, LLC 277,000$10,421,0002.83%
PARSONS CAPITAL MANAGEMENT INC/RI 455,137$17,122,0001.67%
RTW INVESTMENTS, LP 1,511,337$56,857,0001.37%
Avoro Capital Advisors LLC 1,500,000$56,430,0000.80%
Pegasus Asset Management, Inc. 26,958$1,014,0000.64%
RA Capital Management 781,290$29,392,0000.54%
TIEDEMANN ADVISORS, LLC 269,839$10,151,0000.49%
Boxer Capital, LLC 300,000$11,286,0000.39%
View complete list of RELMADA THERAPEUTICS INC shareholders